Vireo Growth (VREOF) Operating Margin (2020 - 2026)
Vireo Growth's (VREOF) quarterly Operating Margin came in at 8.47% in Q1 2026, up 31.0% year-on-year from 6.47% in Q1 2025, and up 588.13% quarter-over-quarter from 1.74% in Q4 2025.
Vireo Growth (VREOF) Operating Margin (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Operating Margin across 7 years of filings, most recently posting 8.47% for Q1 2026.
- Operating Margin for Q1 2026 came in at 8.47%, up 31.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.71% (down 912.0% YoY), and the FY2025 annual result was 0.39%, down 1404.0% from the prior year.
- Operating Margin came in at 8.47% for Q1 2026 at Vireo Growth, up from 1.74% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 23.8% in Q3 2023 to a low of 49.62% in Q1 2022.
- The 5-year median for Operating Margin is 1.93% (2023), against an average of 3.75%.
- Across the five-year window, Operating Margin soared 6416 bps in 2022 and plunged 2728 bps in 2025, its largest moves.
- Vireo Growth's Operating Margin stood at 3.69% in 2022, then soared by 504 bps to 22.26% in 2023, then slumped by 115 bps to 3.36% in 2024, then jumped by 48 bps to 1.74% in 2025, then surged by 588 bps to 8.47% in 2026.
- The last three Operating Margin figures came in at 8.47% (Q1 2026), 1.74% (Q4 2025), and 0.88% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Vireo Growth | - | - | 59.30 Mn | 8.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.47% |
| Dec 31, 2025 | -1.74% |
| Sep 30, 2025 | 0.88% |
| Jun 30, 2025 | -4.20% |
| Mar 31, 2025 | 8.16% |
| Dec 31, 2024 | -3.36% |
| Sep 30, 2024 | 15.30% |
| Jun 30, 2024 | 23.08% |
| Mar 31, 2024 | 19.76% |
| Dec 31, 2023 | 22.26% |
| Sep 30, 2023 | 23.80% |
| Jun 30, 2023 | -5.16% |
| Mar 31, 2023 | 1.93% |
| Dec 31, 2022 | 3.69% |
| Sep 30, 2022 | -1.00% |
| Jun 30, 2022 | 1.46% |
| Mar 31, 2022 | -49.62% |
| Dec 31, 2021 | -60.47% |
| Sep 30, 2021 | -30.90% |
| Jun 30, 2021 | -22.82% |